{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:36:53Z","timestamp":1775248613281,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T00:00:00Z","timestamp":1303948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s12282-011-0269-2","type":"journal-article","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T09:34:50Z","timestamp":1303896890000},"page":"504-507","source":"Crossref","is-referenced-by-count":14,"title":["A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy"],"prefix":"10.1007","volume":"21","author":[{"given":"Haruko","family":"Takuwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Kanao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Toi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,28]]},"reference":[{"issue":"4","key":"269_CR1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/(SICI)1096-9098(199908)71:4<220::AID-JSO3>3.0.CO;2-L","volume":"71","author":"TC Chao","year":"1999","unstructured":"Chao TC, Wang CS, Chen SC, Chen MF. Metaplastic carcinomas of the breast. J Surg Oncol. 1999;71(4):220\u20135.","journal-title":"J Surg Oncol"},{"issue":"1","key":"269_CR2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1245\/s10434-006-9124-7","volume":"14","author":"CM Pezzi","year":"2007","unstructured":"Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007;14(1):166\u201373.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"269_CR3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/02841860500513235","volume":"45","author":"AD Al Sayed","year":"2006","unstructured":"Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol. 2006;45(2):188\u201395.","journal-title":"Acta Oncol"},{"issue":"4","key":"269_CR4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/annonc\/mdl006","volume":"17","author":"BT Hennessy","year":"2006","unstructured":"Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA, et\u00a0al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol. 2006;17(4):605\u201313.","journal-title":"Ann Oncol"},{"issue":"9","key":"269_CR5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/000313480507100906","volume":"71","author":"GR Gibson","year":"2005","unstructured":"Gibson GR, Qian D, Ku JK, Lai LL. Metaplastic breast cancer: clinical features and outcomes. Am Surg. 2005;71(9):725\u201330.","journal-title":"Am Surg"},{"issue":"4","key":"269_CR6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1008329910362","volume":"10","author":"D Rayson","year":"1999","unstructured":"Rayson D, Adjei AA, Suman VJ, LE Wold, Ingle JN. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol. 1999;10(4):413\u20139.","journal-title":"Ann Oncol"},{"issue":"5","key":"269_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.amjsurg.2006.01.038","volume":"191","author":"JD Beatty","year":"2006","unstructured":"Beatty JD, Atwood M, Tickman R, Reiner M. Metaplastic breast cancer: clinical significance. Am J Surg. 2006;191(5):657\u201364.","journal-title":"Am J Surg"},{"issue":"3","key":"269_CR8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2005.08.024","volume":"64","author":"G Dave","year":"2006","unstructured":"Dave G, Cosmatos H, Do T, Lodin K, Varshney D. Metaplastic carcinoma of the breast: a retrospective review. Int J Radiat Oncol Biol Phys. 2006;64(3):771\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"269_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2006.02467.x","volume":"49","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, et\u00a0al. Metaplastic breast carcinomas are basal-like tumours. Histopathology. 2006;49(1):10\u201321.","journal-title":"Histopathology"},{"issue":"5","key":"269_CR10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MC Cheang","year":"2008","unstructured":"Cheang MC, Voduc D, Bajdik C, Leung S, Mc Kinney S, Chia SK, et\u00a0al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14(5):1368\u201376.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"269_CR11","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, et\u00a0al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005;11(16):5678\u201385.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"269_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-004-1001-0","volume":"90","author":"SD Heys","year":"2005","unstructured":"Heys SD, Sarkar T, Hutcheon AW. Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival. Breast Cancer Res Treat. 2005;90(2):169\u201385.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"269_CR13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.20.6.1456","volume":"20","author":"IC Smith","year":"2002","unstructured":"Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, et\u00a0al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 2002;20(6):1456\u201366.","journal-title":"J Clin Oncol"},{"issue":"4","key":"269_CR14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31818ab26e","volume":"33","author":"E Downs-Kelly","year":"2009","unstructured":"Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma. Am J Surg Pathol. 2009;33(4):534\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"269_CR15","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2007.13.1748","volume":"26","author":"EA Rakha","year":"2008","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol. 2008;26(15):2568\u201381.","journal-title":"J Clin Oncol"},{"issue":"1","key":"269_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12282-007-0016-x","volume":"15","author":"M Kurosumi","year":"2008","unstructured":"Kurosumi M, Akashi-Tanaka S, Akiyama F, Komoike Y, Mukai H, Nakamura S, et\u00a0al. Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer. 2008;15(1):5\u20137.","journal-title":"Breast Cancer"},{"issue":"4","key":"269_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1200\/JCO.2008.17.2650","volume":"27","author":"J Schwarz-Dose","year":"2009","unstructured":"Schwarz-Dose J, Untch M, Tiling R, Sassen S, Mahner S, Kahlert S, et\u00a0al. Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose. J Clin Oncol. 2009;27(4):535\u201341.","journal-title":"J Clin Oncol"},{"issue":"34","key":"269_CR18","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.05.7406","volume":"24","author":"C Rousseau","year":"2006","unstructured":"Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L, et\u00a0al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2006;24(34):5366\u201372.","journal-title":"J Clin Oncol"},{"issue":"1","key":"269_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2325\/jbcs.13.38","volume":"13","author":"K Kuroi","year":"2006","unstructured":"Kuroi K, Toi M, Tsuda H, Kurosumi M, Akiyama F. Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Breast Cancer. 2006;13(1):38\u201348.","journal-title":"Breast Cancer"},{"issue":"3","key":"269_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-007-9744-z","volume":"110","author":"M Toi","year":"2008","unstructured":"Toi M, Nakamura S, Kuroi K, Iwata H, Ohno S, Masuda N, et\u00a0al. Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat. 2008;110(3):531\u20139.","journal-title":"Breast Cancer Res Treat"},{"issue":"28","key":"269_CR21","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, et\u00a0al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25(28):4414\u201322.","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-011-0269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-011-0269-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-011-0269-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T08:16:32Z","timestamp":1637568992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-011-0269-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,28]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1007\/s12282-011-0269-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,28]]}}}